Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Confirms Takeover Feeler

NEW YORK, Oct. 8 (GenomeWeb News) – London-based Amersham today announced that it has received a possible takeover bid.

In a short written statement, Amersham, the diagnostics and healthcare giant, said it has received an approach from an unnamed party that “may or may not lead to an offer for the company as a whole.”

The short statement , available on the company website, said “no agreement has been reached and a further announcement will be made as appropriate.”

The statement was released in response to a sharp rise in its share prices today.

Published reports speculated that the buyer could be companies like Johnson & Johnson or Roche Holding.

The 10,000-employee company has a market capitalization of $7.5 billion.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.